All published articles of this journal are available on ScienceDirect.

CASE REPORT

Reworsening of Recurrent Guillain-Barré Syndrome Triggered by COVID-19 Infection

The Open Neurology Journal 10 Nov 2021 CASE REPORT DOI: 10.2174/1874205X02115010048

Abstract

Introduction:

Guillain-Barré Syndrome (GBS) is an acute, immune-mediated, generalized polyradiculoneuropathy often triggered by a bacterial or viral infection, vaccination, or surgery. During the SARS-CoV-2 pandemic, some patients were reported with GBS associated COVID-19 infection.

Case Presentation:

We report, herein, a patient who had a recurrent GBS after forty years. Intravenous immunoglobulins (IVIg) induced improvement, but her condition worsened suddenly after twenty days, coinciding with a COVID-19 infection. A second IVIg cycle was administered, and she improved again.

Conclusion:

The take-home message is that in the current pandemic, any re-worsening or lack of improvement after appropriate treatment of GBS or possibly other autoimmune neurological diseases must be checked to determine if it is related to COVID-19 infection.

Keywords: COVID-19, SARS-CoV-2, Guillain-Barré syndrome, Recurrence, Intravenous immunoglobulins, Pandemic.
Fulltext HTML PDF ePub
1800
1801
1802
1803
1804